These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9250546)
1. A review of the effects of plasmapheresis on drug clearance. Kale-Pradhan PB; Woo MH Pharmacotherapy; 1997; 17(4):684-95. PubMed ID: 9250546 [TBL] [Abstract][Full Text] [Related]
2. Drug removal by plasmapheresis: an evidence-based review. Ibrahim RB; Liu C; Cronin SM; Murphy BC; Cha R; Swerdlow P; Edwards DJ Pharmacotherapy; 2007 Nov; 27(11):1529-49. PubMed ID: 17963462 [TBL] [Abstract][Full Text] [Related]
3. Medications in patients treated with therapeutic plasma exchange: prescription dosage, timing, and drug overdose. Ibrahim RB; Balogun RA Semin Dial; 2012; 25(2):176-89. PubMed ID: 22321259 [TBL] [Abstract][Full Text] [Related]
4. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation. De Buck SS; Mackie CE Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030 [TBL] [Abstract][Full Text] [Related]
5. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs]. Zhang Q; Wang GJ Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605 [TBL] [Abstract][Full Text] [Related]
6. [Adverse effects of drugs induced by transporter-mediated tissue distribution and elimination]. Kusuhara H Chudoku Kenkyu; 2008 Jan; 21(1):13-27. PubMed ID: 18277549 [No Abstract] [Full Text] [Related]
7. How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases? Kawasaki CI; Nishi R; Uekihara S; Hayano S; Kragh-Hansen U; Kawasaki CI; Otagiri M Clin Toxicol (Phila); 2005; 43(2):95-9. PubMed ID: 15822760 [TBL] [Abstract][Full Text] [Related]
8. [Adjusting dosage of drugs in patients with kidney or liver failure]. Krähenbühl S Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139 [TBL] [Abstract][Full Text] [Related]
9. [Effects of liver disease on drug pharmacokinetics]. Su CY Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457 [No Abstract] [Full Text] [Related]
10. Side effects of drugs in the elderly. German PS; Klein LE Compr Ther; 1986 Apr; 12(4):3-5. PubMed ID: 3698555 [No Abstract] [Full Text] [Related]
11. [How to identify and prevent pharmacokinetically relevant drug-drug interactions]. Ritter CA Med Monatsschr Pharm; 2009 Oct; 32(10):364-74; quiz 375-6. PubMed ID: 19886226 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
15. Prediction of human pharmacokinetics - renal metabolic and excretion clearance. Fagerholm U J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256 [TBL] [Abstract][Full Text] [Related]
16. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819 [TBL] [Abstract][Full Text] [Related]
17. First-principle, structure-based prediction of hepatic metabolic clearance values in human. Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Kortejärvi H; Urtti A; Yliperttula M Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967 [TBL] [Abstract][Full Text] [Related]
20. Alterations in drug sensitivity and pharmacokinetics in the elderly. Feldman R Iowa Med; 1985 May; 75(5):224-6. PubMed ID: 3997439 [No Abstract] [Full Text] [Related] [Next] [New Search]